Clinical Professor of Pediatrics, UCSF
Pediatric Endocrinology
Dr. Stephen E. Gitelman, MD
|
|
Give Review
Doctor Stephen E. Gitelman, MD is an expert in the field of Pediatric Endocrinology. He researched medicine at University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is a one of the best medicals schools. University of North Carolina at Chapel Hill School of Medicine is ranked 22/2 in Research/PrimaryCare. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Dr. Stephen E. Gitelman is a published MD. He has 60 papers published. The most current publication "Smooth muscle expresses bone morphogenetic protein (Vgr-1/BMP-6) in human fetal intestine."
Publications
- Recommendations for the Definition of Clinical Responder in Insulin Preservation Studies.
- Co-Stimulation Modulation with Abatacept in Patients with Recent-Onset Type 1 Diabetes: Follow-Up One Year After Cessation of Treatment.
- Antithymocyte globulin treatment for patients with recent-onset type 1 Diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.
- Targeting of memory T cells with alefacept in new-onset type 1 Diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.
- B-Lymphocyte Depletion with Rituximab and Beta-Cell Function: Two-Year Results.
- Combined pancreatic islet and kidney transplantation in a child with unstable type 1 Diabetes and end-stage renal disease.
- Altering the course of type 1 Diabetes: an update on prevention and new-onset clinical trials.
- Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 Diabetes in a randomized controlled trial: Metabolic and immunologi...
- Interleukin-1 antagonism in type 1 Diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
- A Comparison of Autoantibody Positive and Autoantibody Negative Pediatric Participants Enrolled in the T1D Exchange Clinic Registry.
- Immune Therapy and β-Cell Death in Type 1 Diabetes.
- Teplizumab treatment may improve C-peptide responses in participants with type 1 Diabetes after the new-onset period: a randomised controlled trial.
- Impact of an interactive online nursing educational module on insulin errors in hospitalized pediatric patients.
- Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic Diabetes insipidus and nephrogenic syndrome of inappropriat...
- Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 Diabetes mellitus.
- Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 Diabetes: results of a blinded controlled study.
- Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients.
- Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children.
- A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after o...
- Nephrogenic syndrome of inappropriate antidiuresis.
- A two-center randomized controlled feasibility trial of insulin pump therapy in young children with Diabetes.
- Anti-CD3 monoclonal antibody in new-onset type 1 Diabetes mellitus.
- Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 Diabetes mellitus.
- Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass.
- Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients.
- Increased incidence in post-transplant Diabetes mellitus in children: a case-control analysis.
- Treatment of patients with new onset Type 1 Diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.
- Relation of body fat indexes to Vitamin D status and deficiency among obese adolescents.
- Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
- Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis.
- Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.
- Congenital hyperinsulinism in an infant caused by a macroscopic insulin-producing lesion.
- The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 Diabetes mellitus.
- Prevalence and characteristics of type 2 Diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis.
- Insulin secretion in type 1 Diabetes.
- The use of a continuous glucose monitoring system in hypoglycemic disorders.
- Detecting and treating hyperlipidemia in children with type 1 Diabetes mellitus: are standard guidelines applicable to this special population?
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 Diabetes: a randomised double-blind trial.
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 Diabetes: a randomised, double-blind, placebo-controlled trial.
- Analysis of the duplicated human C4/P450c21/X gene cluster.
- Cloning of the LH/CG receptor: implications for a unique G-protein coupled receptor.
- Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus.
- Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia.
- Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus.
- Purification of calmodulin from Chlamydomonas: calmodulin occurs in cell bodies and flagella.
- Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.
- Abundant adrenal-specific transcription of the human P450c21A "pseudogene".
- Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B.
- Toward a molecular understanding of skeletal development.
- Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo.
- Mental retardation locus in Xp21 chromosome microdeletion.
- Congenital lipoid adrenal hyperplasia--genes for P450scc, side chain cleavage enzyme, are normal.
- A promoter within intron 35 of the human C4A gene initiates abundant adrenal-specific transcription of a 1 kb RNA: location of a cryptic CYP21 promoter element?
- Immunoreactive inhibin, müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors.
- Structure and sequence of the mouse Bmp6 gene.
- Idiopathic hypothalamic Diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents.
- Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's Disease.
- Neonatal hyperinsulinism.
- Smooth muscle expresses bone morphogenetic protein (Vgr-1/BMP-6) in human fetal intestine.
Schools
University of North Carolina At Chapel Hill
Procedures Preformed
- Continuous Glucose Monitoring
Conditions Treated
- Diabetes Type 1
- Diabetes Type 2
- Hashimoto's Disease
- Hyperlipidemia
- View All
Doctors Specialties
- Pediatric Endocrinology
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Power Select HMO
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- Brown & Toland Physicians
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Delta Health System
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- WholeCare Network HMO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
UCSF -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Robert A. Lustig, MD |
|
|
Dr. Selna L. Kaplan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thu P. Ho, MD |
|
|
Dr. Melvin M. Grumbach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Schriock, MD |
|
|
Dr. Saleh Adi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua W. Tarkoff, MD |